Does left atrial function and stiffness predict adverse clinical outcomes in HFpEF patients with and without T2DM?
LAS-peak is a powerful predictor of adverse clinical outcomes and may be crucial for risk stratification in HFpEF patients regardless of T2DM status.
Left atrium reservoir and pump function are impaired, whereas LA stiffness is increased in HFpEF patients with T2DM compared with those without T2DM. LAS-peak is a powerful predictor of adverse clinical outcomes and may be crucial for risk stratification in HFpEF patients with and without T2DM.
Zhu et al. (Wed,) studied this question.